| DEXLANSOPRAZOLE | Takeda | ||
| 30MG ; TABLET,ORALLY DISINTEGRATING,DELAYED RELEASE |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| DEXILANT SoluTab delayed-release orally disintegrating tablets (DEXILANT SoluTab) are indicated in patients 12 years of age and older for: • Maintenance of healed EE and relief of heartburn. • Treatment of symptomatic non-erosive GERD. | |||
|
Yes
| |||
| DEXILANT SOLUTAB | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||
| ******* ************* ***** *********** | ****** ** ******** * ***** ********* (**** ******* ****) **** ** *** *** *** ********* ******* | ****** ************* ******* | ****** ************* ******* | ****** ************* ******* | ************* ******** ******* | ************* ******** ******* | ************* ******** ******* | ******* *** *** *************** ** (*)- ** (*)-************ | ************* ******** ******* | ********** ******* *********** | ******** *** ****** **** | ****** *** ********* ******** | ******** *** ****** **** | ****** *** ********* ******** | ******-************** ***** *********** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|